IMPORTANT: Beginning at 8:00 AM on July 22, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.

800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Thomas Fekete Offers Insight to WHYY about Merck’s New Drug Molnupiravir, Which Could Be the First Pill to Treat COVID-19

View All News

Thomas Fekete, MD, MACP, Thomas Durant Chair and Professor of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, offered insight to WHYY about Merck’s new drug molnupiravir, which could be the first pill to treat COVID-19. Merck has asked the U.S. Food and Drug Administration to authorize the treatment.